Document Detail


Fibrinogen synthesis is increased in cachectic patients with chronic heart failure.
MedLine Citation:
PMID:  18022259     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Cachexia is common in chronic heart failure (CHF) and may be due to a combination of reduced appetite, and increased metabolic rate due to immune activation. This hypermetabolism, with an increase in acute phase protein turnover, also seen in cancer cachexia, might contribute to weight loss seen in severe CHF. We investigated the rate of hepatic fibrinogen synthesis by measuring the rate of incorporation of deuterated phenylalanine into circulating plasma fibrinogen. METHODS: 14 male patients with CHF, 9 with a history of weight loss each received an infusion containing 3500 mg of l-phenylalanine and 350 mg [(2)H(5)]l-phenylalanine. Blood drawn at intervals allowed measurement of the rate of [(2)H(5)]-phenylalanine enrichment in fibrinogen by gas chromatography-mass spectrometry. RESULTS: Cachectic and non-cachectic patients had similar age and CHF severity. Cachectic patients had lower body mass index (BMI), and corrected arm muscle area (CAMA). The logarithmic derivatives of CRP and IL-6 were greater in the cachectic than the non-cachectic subjects (0.99 (0.38) v 0.44 (0.35); p=0.015 and 1.25 (0.50) v 0.86 (0.15); p=0.09). Total plasma fibrinogen (TF), relative fibrinogen synthesis rate (FSR) and absolute synthesis rate (ASR) were greater in those with cachexia. There were inverse relationships between TF and indices of body habitus: CAMA (r=0.62; p<0.02) and BMI (r=0.55; p<0.05). TF was related to CRP (r=0.69; p<0.007). CONCLUSION: Patients with CHF and cachexia have an increased hepatic fibrinogen synthesis rate related to the level of C-reactive protein. It is possible that increased protein turnover is one of the causes of weight loss in patients with severe heart failure.
Authors:
Klaus K A Witte; Sarah J Ford; Tom Preston; John D Parker; Andrew L Clark
Related Documents :
19947809 - Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: ca...
20493419 - Clinical profile and management of patients with chronic ischemic heart disease accordi...
20577129 - Increased pulse wave velocity and not reduced ejection fraction is associated with impa...
3436149 - Intraaortic balloon counterpulsation.
12371009 - Transposition complexes in the adult: a changing perspective.
24331009 - Relationship of body mass index and waist-to-hip ratio with fibrinolytic activity measu...
15853979 - Characteristics of gastritis in patients with helicobacter pylori-positive reflux esoph...
12170409 - Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duc...
793369 - Clinical efficacy of amiodarone as an antiarrhythmic agent.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-11-19
Journal Detail:
Title:  International journal of cardiology     Volume:  129     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2010-02-23     Completed Date:  2010-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  363-7     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Leeds General Infirmary, Great George Street, Leeds, LS1, UK. klauswitte@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Cachexia / complications*,  metabolism*
Chronic Disease
Fibrinogen / biosynthesis*
Heart Failure / complications*,  metabolism*
Humans
Male
Chemical
Reg. No./Substance:
9001-32-5/Fibrinogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial infarcts in a patient with a single right sided coronary ostium and interarterial course ...
Next Document:  VGAM induced high-flow congestive heart failure responsive to PGE1 infusion.